To view the PDF file, sign up for a MySharenet subscription.

ACUCAP PROPERTIES LIMITED - Proposed restructure and adoption of a new memorandum of incorporation

Release Date: 27/03/2014 07:05
Code(s): ACP     PDF:  
Wrap Text
Proposed restructure and adoption of a new memorandum of incorporation

Acucap Properties Limited 
(Incorporated in the Republic of South Africa) 
(Registration number 2001/021725/06) 
Share code: ACP 
ISIN: ZAE000037651 
(Approved as a REIT by the JSE) 
("Acucap" or "the Company") 
 
PROPOSED RESTRUCTURE THROUGH THE SUBSTITUTION OF THE LINKED UNITS FOR NO 
PAR VALUE SHARES, ADOPTION OF A NEW MEMORANDUM OF INCORPORATION AND THE 
CREATION OF 500 000 000 AUTHORISED NO PAR VALUE SHARES 
 
1. INTRODUCTION 
 
Acucap qualified as a Real Estate Investment Trust ("REIT") with effect from the commencement 
of its current financial year, being 1 April 2013, following the approval by the JSE of its REIT status. 

It is accordingly no longer required that Acucap maintains its current capital structure 
comprising of variable rate, subordinated debentures ("the debentures") each of which is 
indivisibly linked to a share, together comprising a linked unit. 

The board of directors of Acucap ("the Board") is therefore proposing that Acucap's current 
linked unit capital structure be replaced with a pure equity, share-only structure ("the 
Acucap Restructure").  

The Acucap Restructure comprises the following inter-conditional steps: 

   1.1.   a substitutive share-for-share transaction in terms of section 43 of the Income Tax 
          Act, 58 of 1962, as amended (the "Tax Act") in terms of which Acucap will 
          substitute/exchange the issued linked units for no par value shares, resulting in 
          Acucap linked unitholders becoming holders of no par value shares and pursuant 
          whereto the linked units will be cancelled ("the Substitution");  
   1.2.   the adoption of a new Memorandum of Incorporation ("New MOI") as further 
          described in paragraph 4 below; and 
   1.3.   the creation of 500 000 000 authorised no par value shares for the purpose of, inter alia, the 
          Substitution. 
 
2. RATIONALE FOR THE ACUCAP RESTRUCTURE 
 
The Tax Act now contemplates the flow through of net income by a REIT to its 
investors, notwithstanding the legal form of the instrument held by investors, thereby 
obviating the need for a linked unit structure. 

In addition, in terms of the recently revised section 13 of the JSE Listings Requirements, 
REITs are required to ensure that their total consolidated liabilities do not exceed 60% of 
their consolidated assets. 
 
An application of International Financial Reporting Standards (which is applicable to all JSE-
listed companies) results in the debenture component of the linked units (even though 
subordinated) being included in the calculation of total consolidated liabilities, effectively 
distorting this ratio of debt to assets.  A share only capital structure will mean that Acucap 
will have additional headroom to take on additional debt should the need arise and 
therefore the flexibility to pursue an acquisitive growth strategy whilst limiting potential 
shareholder dilution. 

Accordingly, the board of Acucap is proposing that the Acucap linked unit capital structure 
should be replaced by a share only capital structure. 
 
3. THE MECHANICS OF THE ACUCAP RESTRUCTURE, CIRCULAR TO LINKED UNITHOLDERS 
   AND FAIR AND REASONABLE OPINION 
 
The Substitution is proposed to be implemented in terms of section 43 of the Tax Act 
("section 43") by way of a scheme of arrangement as contemplated in sections 114 and 115 
of the Companies Act No. 71 of 2008 ("the Act"), in terms of which each linked unit in issue 
will be replaced in its entirety with a no par value share. The effect of section 43 is that 
resident linked unitholders should expect to qualify for roll-over relief and as such should 
not be subject to any tax liability as a result of the Acucap Restructure.  
 
Section 114 of the Act requires that the Company obtain an opinion from an independent 
expert on whether the terms of the scheme of arrangement are fair and reasonable to 
scheme participants. In compliance with the aforementioned, Acucap has engaged Mazars 
Corporate Finance (Pty) Ltd ("Mazars"), which has provided the Board with an opinion 
stating that the terms of the Substitution are fair and reasonable as far as linked unitholders 
of Acucap are concerned.  

In terms of section 115 of the Act, a scheme of arrangement must be approved in terms of a 
special resolution of shareholders. In addition, the abrogation of the current Memorandum 
of Incorporation of Acucap in its entirety and the subsequent adoption of the New MOI, 
along with the creation of 500 000 000 authorised no par value shares, requires approval by 
linked unitholders by way of special resolutions.  

A circular containing further information pertinent to, inter alia, the Acucap Restructure and 
notices of general meeting of linked unitholders in their capacity as Acucap shareholders 
and Acucap debenture holders, respectively ("General Meetings") for the purpose of 
considering and, if deemed fit, passing, the requisite shareholder and debenture holder 
resolutions and which includes a copy of the fair and reasonable opinion, will be posted to 
linked unitholders on  or about 31 March 2014 ("the Circular"). 
 
4. ADOPTION OF THE NEW MOI  
 
In order to enable linked unitholders to make an assessment of whether they consider their 
rights or interests to be affected as a result of the adoption of the New MOI, a summary of 
the salient terms of the New MOI and the current Memorandum of Incorporation of Acucap 
will be included in the Circular. In addition, linked unitholders seeking additional 
information will be able to access the complete New MOI and the current Memorandum of 
Incorporation of Acucap on Acucap's website, www.acucap.co.za with effect from the date 
of posting of the Circular (on or/about 31 March 2014) to the date of the General Meetings 
(being 5 May 2014). Copies of both the New MOI and the current Memorandum of 
Incorporation of Acucap will also be available for inspection at Acucap's registered office for 
the same period. 
 
5. INDICATIVE SUPPORT FOR THE ACUCAP RESTRUCTURE 
 
Acucap has received indicative support from linked unitholders, collectively 
holding 32% of the Acucap linked units, to vote in favour of the Acucap 
Restructure at the General Meetings. 
      
6. CONDITIONS PRECEDENT 
 
The implementation of the Acucap Restructure is subject to the fulfilment or, where possible, 
waiver, of, inter alia, the following conditions precedent: 

   6.1. approval by linked unitholders of the Substitution by way of a scheme of 
        arrangement; 

   6.2. approval by linked unitholders of the adoption of the New MOI by way of a 
        shareholders' special resolution and linked unitholder approval for the creation of 
        the no par value shares; 

   6.3. confirmation by the Companies and Intellectual Property Commission ("CIPC") that 
        it has accepted and placed on file all the relevant documents required to effect the 
        Acucap Restructure; and 

   6.4. such other regulatory and other approvals, as fully detailed in the Circular.     
                     
7. SALIENT DATES AND TIMES 

                                                                                     2014

Record date to be sent Notices of General Meetings                     Thursday, 20 March 

Circular incorporating Notices of General Meetings, Proxy Forms          Monday, 31 March 
and Form of Surrender posted to linked unitholders, on or about  

Last day to trade in order to be eligible to vote at the General      Wednesday, 16 April 
Meetings  

Record date in order to be eligible to participate in and vote at        Friday, 25 April 
the General Meetings ("Record Date") 

Last day to lodge Proxy Forms in respect of the General Meeting       Wednesday, 30 April 
with the Transfer Secretaries by 9:00 on  

Last date for shareholders objecting to the Acucap Restructure to           Monday, 5 May
notify Acucap of their objection ("objecting linked unitholders") in 
terms of section 164(3) of the Act before 9:00 

General Meeting of Acucap Shareholders held at 9:00 on                      Monday, 5 May 

General Meeting of Acucap Debenture Holders held immediately                Monday, 5 May 
after the conclusion of the General Meeting of Acucap 
Shareholders 

Results of the General Meetings and finalisation announcement               Monday, 5 May 
released on SENS on 

Results of the General Meetings  and finalisation announcement             Tuesday, 6 May
published in the South African press on 

Acucap to send objecting shareholders (if any) notices of the              Tuesday, 6 May
adoption of the Acucap Restructure in terms of section 164(4) of 
the Act 
Last date for a shareholder, who voted against the passing of the         Tuesday, 13 May
shareholder and debenture holder resolutions proposing the 
Substitution, to require Acucap to apply to court for approval of 
the Substitution, if 15% or more of the voting rights exercised 
were against the resolution, under section 115(3)(a) of the Act 

Last date for Acucap to apply to the court for approval of the            Tuesday, 20 May
Substitution in the event that sufficient objections thereto are 
received under section 115(3)(b) of the Act  

Last date for dissenting Acucap linked unitholders to deliver a           Tuesday, 3 June
written notice to Acucap demanding Acucap to pay the fair value 
of all Acucap linked units held by such linked unitholders under 
section 164 of the Act  

Expected finalisation date of the Acucap Restructure (see note 1)       Wednesday, 4 June
Last date to trade in Acucap linked units under the current ISIN          Friday, 20 June
number ZAE000037651 at the close of business on 

Listing of 183 511 083 no par value shares issued pursuant to the         Friday, 20 June
Substitution under share code ACP and new ISIN number 
ZAE000188660 at 9:00 on 

Suspension of the listing of Acucap linked units on the JSE under         Monday, 23 June
the previous ISIN number ZAE000037651 from commencement of 
trade on 

Expected record date for the Acucap Restructure                           Friday, 27 June
Expected date on which CSDP/broker accounts will be credited              Monday, 30 June
with the no par value shares and statements reflecting no par 
value shareholdings will be posted to certificated linked 
unitholders  ("Pay Date") 

Expected date of termination of listing of Acucap linked units at         Monday, 30 June
the commencement of business on 

 
1.   The above dates and times are subject to change. Any material changes will be released on SENS and in the South 
     African press. It should be noted that if the Acucap Restructure is approved at the General Meetings it is still required 
     to be implemented through certain filings at the CIPC. Acucap does not have control over the timing and processes at 
     the CIPC. 

2.   All times quoted in this Circular are local times in South Africa.   

3.   If the General Meetings are adjourned or postponed, proxy forms submitted for the initial General Meetings will 
     remain valid in respect of any adjournment or postponement of the General Meetings unless withdrawn by the 
     Acucap Shareholder or debenture holders concerned.   

4.   The Pay Date of 30 June 2014 is dependent on the fulfilment and/or waiver of the Conditions Precedent referred to in 
     paragraph 6.  
      
8.   FINANCIAL EFFECTS  
 
Earnings and headline earnings per no par value share for the six months ended 30 September 2013 and the net asset value and tangible 
net asset value as at 30 September 2013, calculated after the implementation of the Acucap Restructure, will be unchanged from the 
earnings and, headline earnings per linked unit for the six months ended 30 September 2013 and the net asset value and tangible net 
asset value per linked unit as at 30 September 2013 respectively, before the implementation of the Acucap Restructure, save for the 
effect of transaction costs. The transaction costs will have a less than 3% effect on earnings, headline earnings, net asset value and 
tangible net asset per linked unit/no par value share and as such are not disclosed.

Cape Town 

26 March 2014 
 
Corporate Advisor and Sponsor  
QUESTCO 
 
Legal and tax advisor to Acucap on the Acucap Restructure 
ENS 
 
Independent Expert on the Acucap Restructure 
MAZARS 

Date: 27/03/2014 07:05:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.

Share This Story